0001062993-16-011291.txt : 20160824 0001062993-16-011291.hdr.sgml : 20160824 20160824194054 ACCESSION NUMBER: 0001062993-16-011291 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160823 FILED AS OF DATE: 20160824 DATE AS OF CHANGE: 20160824 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP CENTRAL INDEX KEY: 0000875622 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113054851 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 WILBUR ST CITY: LYNBROOK STATE: NY ZIP: 11563 BUSINESS PHONE: 5165937000 MAIL ADDRESS: STREET 1: 35 WILBUR STREET CITY: LYNBROOK STATE: NY ZIP: 11563 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wegman Thomas CENTRAL INDEX KEY: 0001355189 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34236 FILM NUMBER: 161850246 MAIL ADDRESS: STREET 1: 1764 BRIAR PLACE CITY: MERRICK STATE: NY ZIP: 11566 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4 2016-08-23 0000875622 BIOSPECIFICS TECHNOLOGIES CORP BSTC 0001355189 Wegman Thomas C/O BIOSPECIFICS TECHNOLOGIES CORP., 35 WILBUR STREET LYNBROOK NY 11563 1 1 1 0 President Common Stock, $0.001 par value 2016-08-23 4 S 0 4100 38.6048 D 191722 D Common Stock, $0.001 par value 2016-08-24 4 S 0 4173 38.0773 D 187549 D The selling price of $38.6048 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $38.13 to $39.11. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. The selling price of $38.0773 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $38.00 to $38.25. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. /s/ Carl A. Valenstein, attorney-in-fact for Thomas Wegman 2016-08-24